The fact
This deal strengthens its portfolio in innovative therapies and biotechnologies.
It aligns with a targeted external growth strategy.
Click the link to read an article on the topic:
This deal strengthens its portfolio in innovative therapies and biotechnologies.
It aligns with a targeted external growth strategy.